Benlysta 400 mg, Pulver zur Herstellung einer Infusionslösung - Durchstechflasche(n) Swissmedic Key 61532002 PP Registration Holder GlaxoSmithKline AG Name Benlysta 400 mg, Pulver zur Herstellung einer Infusionslösung Date of registration 14.06.2012 Introduction of Sequence 14.06.2012 ATC-Classification (L04AG04) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 07.15. Show package size Durchstechflasche(n) Index Therapeuticus (Swissmedic) 07.15. Description Swissmedic categorie. A SL Eintrag Yes Indication Information for professionals IP Consumer information Ex-factory-Price 521.67 Limitation Yes Limitation text
Deductible 10 % Consumer price 583.75 Feedback FB GTIN 7680615320026 Medication Code Biotechnologika Pharmacode 5278220 Disponibility
Composition Praeparatio cryodesiccata: belimumabum 400 mg, acidum citricum monohydricum, natrii citras dihydricus, saccharum, polysorbatum 80 pro vitro. Packungsbestandteile Label Praeparatio cryodesiccata:
Galenic Form Lyophilisate Excipiens Active Agent Dose Belimumabum 400 mg
BAG: Active Agent Dose Belimumabum 400 mg
Inactive agents Citric Acid Monohydrate Natrii Citras Dihydricus Polysorbatum 80 Saccharum
Source Data was imported : 06.11.2024
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
